Immediate Impact

1 by Nobel laureates 3 from Science/Nature 53 standout
Sub-graph 1 of 24

Citing Papers

Induced pluripotent stem-cell-derived CD19-directed chimeric antigen receptor natural killer cells in B-cell lymphoma: a phase 1, first-in-human trial
2025 Standout
Allogeneic CD33-directed CAR-NKT cells for the treatment of bone marrow-resident myeloid malignancies
2025 Standout
2 intermediate papers

Works of Michael Byrne being referenced

The use of venetoclax‐based salvage therapy for post‐hematopoietic cell transplantation relapse of acute myeloid leukemia
2020
Understanding and Managing Large B Cell Lymphoma Relapses after Chimeric Antigen Receptor T Cell Therapy
2019

Author Peers

Author Last Decade Papers Cites
Michael Byrne 494 598 267 309 77 1.4k
Carsten Grüllich 253 541 483 181 87 1.5k
Juan Li 656 591 268 177 62 1.2k
Keren Borensztajn 368 389 112 137 51 1.4k
Wei Ding 194 919 314 194 65 1.6k
Yuka Sugimoto 718 644 122 101 77 1.5k
Martin Figeac 353 633 200 200 80 1.5k
Peter O’Gorman 853 628 547 120 72 1.7k
Masakazu Nitta 555 759 274 214 80 1.5k
Kumiko Goi 335 652 351 179 77 1.2k
Miki Nishimura 456 415 261 58 49 1.1k

All Works

Loading papers...

Rankless by CCL
2026